Aarti Drugs has announced the approval of an interim dividend by its Board of Directors. The dividend is set at ₹2 per equity share (@ 20%) for the financial year 2025-26. The company has fixed February 9, 2026, as the ‘Record Date’ for determining shareholders eligible for the dividend payout. The dividend distribution underscores the company’s commitment to rewarding its investors.
Interim Dividend Declared
The Board of Directors at Aarti Drugs has officially declared an interim dividend to its shareholders. The decision was made during a board meeting held on February 3, 2026.
Dividend Details
The approved interim dividend stands at ₹2 per equity share, which translates to 20% based on a face value of ₹10 per share. This dividend is intended for the financial year 2025-26, showing a commitment to shareholder returns.
Record Date
Aarti Drugs has set February 9, 2026, as the ‘Record Date’. This date will serve as the cutoff to determine the shareholders who are eligible to receive the interim dividend payout. This action aligns with standard practices for dividend distribution.
Source: BSE
